Search

The Heart Rhythm Society (HRS) has been developing clinical practice documents in collaboration and partnership with other professional medical societies since 1996. The HRS formed a Scientific and Clinical Documents Committee (SCDC) with the sole purpose of managing the development of these documents from conception through publication. The SCDC oversees the process for developing clinical practice documents, with input and approval from the HRS Executive Committee and the Board of Trustees. As of September 2017, the HRS has produced more than 80 publications with other professional organizations. The HRS Clinical Document Development Methodology Manual and Policies transparently declares the standards by which the HRS develops clinical practice documents, which include clinical practice guidelines, expert consensus statements, scientific statements, clinical competency statements, task force policy statements, and proceedings statements. 

July 28, 2007—Amiodarone is commonly used to treat supraventricular and ventricular arrhythmias in various inpatient and outpatient settings. Because of adverse drug reactions, proper use is essential to deriving optimal benefits from the drug with the least risk.

This document has been retired because it is no longer current.

Thousands of clinicians, scientists, researchers and innovators from around the world will gather together Wednesday, May 9 through Saturday, May 12 at the Boston Convention and Exhibition Center for Heart Rhythm 2018, the Heart Rhythm Society’s (HRS) 39th Annual Scientific Sessions, to explore recent developments in the field of cardiac pacing and electrophysiology (EP). The meeting will start with a keynote address by Sherry Turkle who will challenge attendees to think about how technological advancements not only catalyze change but affect ways of thinking. 

According to new research, smoking marijuana may not be associated with an increased risk of ventricular fibrillation (VF) and ventricular tachycardia (VT) following an acute myocardial infarction (AMI), or heart attack. The study also reported that marijuana users had a decreased risk of atrial fibrillation (AFib) and in-hospital mortality. The results are scheduled to be presented on Thursday, May 10 at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions.

A new study is the first to report a relationship between post-traumatic stress disorder (PTSD) and new cases of atrial fibrillation (AF), the most common heart arrhythmia. The large nationwide study included more than 1 million patients with no prior history of AF or atrial flutter. The study is scheduled to be presented on Friday, May 11 at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions.

A new study shows that women exposed to particular matter (PM) and lower temperatures for even a short amount of time are at an increased risk of sudden cardiac death (SCD). PM is a mixture of hazardous, small particle pollutants that includes dust, pollen, soot, smoke and liquid droplets that get into the air. The study is the largest of its kind in the United States to date and is scheduled to be presented on Wednesday, May 9 at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions.

A new study is the first to validate the accuracy of wrist-worn wearable devices in measuring induced paroxysmal supraventricular tachycardia (PSVT), or episodes of rapid heart rate. Three common wearable devices including the Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2, were randomly assigned to patients to measure heart rate. The results of this study are scheduled to be presented on Friday, May 11 at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions.  

January 2003—The provision of services accompanying technology-based electrophysiological-related interventions created an opportunity for health care professionals to specialize in the field of cardiac rhythm management. Known as allied professionals (APs), this diverse group of nurses, physician assistants, technologists, technicians, and engineers is dedicated to promoting excellence in the care of patients with cardiac rhythm disorders.

This document was reaffirmed on February 7, 2018, and will be formally assessed by February 2023.